BU HEAD, CELL THERAPY U.S.
Darren Head currently leads the Catalent Cell & Gene Therapy US Cell Therapy business and was formerly the CEO and a board member at MaSTherCell. He is on the board of GPP III portfolio company BioNova. Mr. Head was the President and CEO of Cytovance Biologics (“Cytovance”), a former GPP I portfolio company and was a board member of GPP II portfolio company Clinical Supplies Management. He has over 26 years of biological, device, and drug manufacturing experience. Prior to joining Cytovance, Mr. Head was a Senior Vice President of Worldwide Operations with Immucor. Prior to Immucor, Mr. Head led Aronex Pharmaceuticals manufacturing and clinical supply operations in late Phase 3 programs. He holds a B.S. in biology and attended the executive M.B.A. program at Texas A&M.